Views & Analysis
Patients/ Views & Analysis/ Views and analysis
A crisis of trust: How lack of sector confidence is threating patient centricity
Amanda Barrell
Novartis, patient centricity, Scott Bradley, trust in pharma
0 Comment
Market Access/ Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis
Saving lives doesn’t have to cost the Earth
mike.hammerton@pharmaphorum.com
climate change, global warming, Jamie Phares, Janssen, Johnson & Johnson, pharma
0 Comment
Digital/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis
To increase clinical trial diversity, build trust in communities and use tech wisely
Jonah Comstock
clinical trial diversity, decentralised clinical trials, marginalised communities, telehealth
0 Comment
Patients/ Views & Analysis/ Views and analysis
Studying inequities throughout the pandemic
Jessica Hagen
COVID-19, vaccines, WHO, world health organization
0 Comment
Patients/ Views & Analysis/ Views and analysis
Transparency, social change can help pharma regain the public’s trust
mike.hammerton@pharmaphorum.com
impetus, Life Sciences, Natalie Yeadon, Transparency, trust
0 Comment
Patients/ Views & Analysis/ Views and analysis
Engagement to partnership: The changing face of patient involvement
Amanda Barrell
Iris Loew-Friedrich, patient engagement, UCB
0 Comment
Patients/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis
Independent health comms agencies rebrand with emphasis on authenticity
Amanda Barrell
healthcare communications, patient engagement, pharma
0 Comment
Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis